Association of Clinical Research Professionals (ACRP) Certified Professional Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the ACRP Certified Professional Exam with our comprehensive quiz. Elevate your clinical research skills with targeted flashcards and multiple-choice questions. Enhance your readiness with detailed explanations and insights for improved performance!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


Should any changes to safety language in an Investigator's Brochure be submitted to the IRB/IEC?

  1. Yes, all changes need to be submitted

  2. No, changes are not necessary

  3. Only significant changes need to be submitted

  4. Only if the IRB requests it

The correct answer is: Yes, all changes need to be submitted

Submitting all changes to safety language in an Investigator's Brochure to the Institutional Review Board (IRB) or Independent Ethics Committee (IEC) is essential for maintaining the integrity and safety of the research protocol. The IRB/IEC plays a crucial role in safeguarding the rights and welfare of participants involved in a clinical trial. As the Investigator’s Brochure serves as a comprehensive resource regarding the investigational product, including its safety profile, any modifications to the safety language could indicate new risks or the need for updates on risk management strategies. The rationale behind this requirement is that any changes, no matter how minor they may seem, could have implications for participant safety or the ethical considerations of the study. By ensuring that all updates are reviewed by the IRB/IEC, researchers uphold ethical standards and transparency, allowing the board to reassess the risk-benefit balance of the study in light of the new information. This accountability ensures that informed consent is based on the most current and comprehensive understanding of the study's risks. In summary, submitting all changes to safety language ensures ongoing oversight and participant protection throughout the trial, aligning with regulatory requirements and best practices in clinical research.